Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

James R. Perry*, Normand Laperriere, Christopher J. O'Callaghan, Alba A. Brandes, Johan Menten, Claire Phillips, Michael Fay, Ryo Nishikawa, J. Gregory Cairncross, Wilson Roa, David Osoba, John P. Rossiter, Arjun Sahgal, Hal Hirte, Florence Laigle-Donadey, Enrico Franceschi, Olivier Chinot, Vassilis Golfinopoulos, Laura Fariselli, Antje WickLoic Feuvret, Michael Back, Michael Tills, Chad Winch, Brigitta G. Baumert, Wolfgang Wick, Keyue Ding, Warren P. Mason, Trial Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1027-1037
Number of pages11
JournalNew England Journal of Medicine
Volume376
Issue number11
DOIs
Publication statusPublished - 16 Mar 2017

Keywords

  • MALIGNANT ASTROCYTOMA
  • PROMOTER METHYLATION
  • PHASE-3 TRIAL
  • RADIOTHERAPY
  • MULTIFORME
  • CHEMOTHERAPY
  • CONCOMITANT
  • PATTERNS
  • ADJUVANT
  • TUMORS

Cite this

Perry, J. R., Laperriere, N., O'Callaghan, C. J., Brandes, A. A., Menten, J., Phillips, C., Fay, M., Nishikawa, R., Cairncross, J. G., Roa, W., Osoba, D., Rossiter, J. P., Sahgal, A., Hirte, H., Laigle-Donadey, F., Franceschi, E., Chinot, O., Golfinopoulos, V., Fariselli, L., ... Trial Investigators (2017). Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. New England Journal of Medicine, 376(11), 1027-1037. https://doi.org/10.1056/NEJMoa1611977